Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Saved in:

Bibliographic Details
Main Authors:	Mossner, Maximilian (Author) , Jann, Johann-Christoph (Author) , Nowak, Daniel (Author) , Pressler, Jovita (Author) , Obländer, Julia (Author) , Fey, Stephanie (Author) , Müller, Nadine Zoé (Author) , Metzgeroth, Georgia (Author) , Weiß, Christel (Author) , Hofmann, Wolf-Karsten (Author) , Nolte, Florian (Author)
Format:	Article (Journal) Editorial
Language:	English
Published:	27 May 2016
In:	Leukemia Year: 2016, Volume: 30, Issue: 9, Pages: 1956-1959
ISSN:	1476-5551
DOI:	10.1038/leu.2016.111
Online Access:	Verlag, Volltext: http://dx.doi.org/10.1038/leu.2016.111 Verlag, Volltext: http://www.nature.com/articles/leu2016111
Author Notes:	M Mossner, J-C Jann, D Nowak, U Platzbecker, A Giagounidis, K Götze, A Letsch, D Haase, K Shirneshan, F Braulke, RF Schlenk, T Haferlach, P Schafhausen, G Bug, M Lübbert, A Ganser, G Büsche, E Schuler, V Nowak, J Pressler, J Obländer, S Fey, N Müller, E Lauinger-Lörsch, G Metzgeroth, C Weiß, W-K Hofmann, U Germing, and F Nolte

Description
Summary:	Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
Item Description:	Gesehen am 04.02.2019
Physical Description:	Online Resource
ISSN:	1476-5551
DOI:	10.1038/leu.2016.111

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Similar Items